Helvoet Pharma Celebrates Groundbreaking Of Its New Production Facility In India

Helvoet Pharma is to build a new modern production facility in India. This new plant will begin operation in 2012 and will supply the local pharmaceutical industry and globally operating pharmaceutical customers with components for primary packaging for parenteral pharmaceutical and diagnostic drugs. The groundbreaking ceremony has taken place on September 24th.

With this facility, Helvoet Pharma is further strengthening its market position in India and establishing its first operational platform in Asia to further capitalise on its worldwide leadership in pharmaceutical rubber formulations.

Helvoet Pharma's decision to build its own manufacturing plant in India has been made to leverage the country's position as the centre of excellence for generic and branded pharmaceutical products. India has the highest number of US FDA approved plants outside the USA and is expected to become a significant healthcare consumer market.

Guido Wallraff, President (or CEO) of Helvoet Pharma: "Our confidence in the Indian market is reflected in our long association with the country. Our engagement dates back to 1991 when we started collaboration in India for distribution of our products."

This brand-new plant fully equipped with state-of-the-art facilities built to Helvoet Pharma's high standards will be operational early 2012. Over the next two years, Helvoet Pharma will spend some 14M Euros. Construction work for the greenfield production facility will start in the coming weeks. The groundbreaking ceremony has taken place on September 24th. The new plant will be located near Pune (Maharashtra state) in a newly developed MIDC Special Economic zone with a secure energy supply, good transport connections and access to trained personnel. If required, the new facility can be expanded modularly in the future.

About Helvoet Pharma – "Passion for Excellence"
Helvoet Pharma, a leading global supplier of primary and secondary pharmaceutical packaging components, was founded in 1970. The company is headquartered in Europe and has additional manufacturing facilities located in Europe, the USA and Asia, supplying over 10 billion parts to the pharmaceutical industry every year. Helvoet Pharma currently employs a total of 1,250 people worldwide and generated sales revenues of 185M euros in 2009. Helvoet Pharma is part of the Swiss Daetwyler Group, which has some 4,600 employees and generates more than 1'000M euros in revenue. For more information, visit www.helvoetpharma.com. For over four decades, Helvoet Pharma has continued to build upon its reputation for reliability, high quality products and customer support.

SOURCE: Helvoet Pharma